Home/Filings/4/0001062993-21-012394
4//SEC Filing

Brenner Erin K. 4

Accession 0001062993-21-012394

CIK 0001835567other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 5:24 PM ET

Size

18.1 KB

Accession

0001062993-21-012394

Insider Transaction Report

Form 4
Period: 2021-12-03
Brenner Erin K.
Chief Product Dev. Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-03+54,92654,926 total
    Exercise: $1.12Exp: 2030-06-23Common Stock (54,926 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-12-03+58,89658,896 total
    Exercise: $1.29Exp: 2031-01-26Common Stock (58,896 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-12-03+44,17144,171 total
    Exercise: $1.08Exp: 2029-03-14Common Stock (44,171 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-12-03+120,234120,234 total
    Exercise: $1.00Exp: 2028-09-20Common Stock (120,234 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-12-03+100,625100,625 total
    Exercise: $1.09Exp: 2030-03-24Common Stock (100,625 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-12-03+21,13521,135 total
    Exercise: $1.12Exp: 2030-06-23Common Stock (21,135 underlying)
Footnotes (12)
  • [F1]25% of the shares underlying the option vested or shall vest on July 16, 2019 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F10]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 14,355 shares of common stock of Private Pear for $1.64 per share.
  • [F11]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F12]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 40,000 shares of common stock of Private Pear for $1.89 per share.
  • [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 81,659 shares of common stock of Private Pear for $1.46 per share.
  • [F3]25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.58 per share.
  • [F5]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 68,341 shares of common stock of Private Pear for $1.60 per share.
  • [F7]25% of the shares underlying the option vested or shall vest on June 23, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F8]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 37,304 shares of common stock of Private Pear for $1.64 per share.
  • [F9]25% of the shares underlying this option vested or shall vest on June 23, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001881042

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:24 PM ET
Size
18.1 KB